Hi FloatingCity if I had the answer to that I would be a very rich women. I know that we are currently priced for failure and as posted previously I know what forward looking numbers should look like upon FDA approval. However we don’t know the cost of product, the numbers who will actually uptake, the amount insurers will pay so all educated guess work. I have my numbers I am sure Mr. Market will have his own ideas.
I agree that I don’t think the end game is Bot developing their own pipeline. Look at the track record of the management team and previous time spent with other companies. They mostly seem to be builders and sellers.
BOT - Anything but charting, page-5049
-
- There are more pages in this discussion • 5,545 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
-0.005(1.18%) |
Mkt cap ! $780.0M | |||
| Open | High | Low | Value | Volume |
| 43.0¢ | 43.3¢ | 42.0¢ | $851.6K | 1.988M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 632949 | 42.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.5¢ | 337712 | 7 |
View Market Depth
| Last trade - 13.08pm 12/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |